Vaxil Bio Stock Performance
| VXL Stock | CAD 0.01 0.00 0.00% |
The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Vaxil Bio are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Vaxil Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Vaxil Bio is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors. ...more
Last Split Factor 1:2 | Last Split Date 2016-03-10 |
1 | Vaxil Bio 14-Day RSI 41.18 - GuruFocus.com | 11/14/2024 |
| Begin Period Cash Flow | 1.5 M |
Vaxil |
Vaxil Bio Relative Risk vs. Return Landscape
If you would invest 1.00 in Vaxil Bio on August 30, 2024 and sell it today you would earn a total of 0.00 from holding Vaxil Bio or generate 0.0% return on investment over 90 days. Vaxil Bio is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded stocks are less volatile than Vaxil, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Vaxil Bio Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vaxil Bio's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Vaxil Bio, and traders can use it to determine the average amount a Vaxil Bio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| VXL |
Based on monthly moving average Vaxil Bio is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vaxil Bio by adding Vaxil Bio to a well-diversified portfolio.
Vaxil Bio Fundamentals Growth
Vaxil Stock prices reflect investors' perceptions of the future prospects and financial health of Vaxil Bio, and Vaxil Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Vaxil Stock performance.
| Return On Equity | -0.2 | ||||
| Return On Asset | -0.1 | ||||
| Current Valuation | 449.79 K | ||||
| Shares Outstanding | 136.98 M | ||||
| Price To Earning | (1.40) X | ||||
| Price To Book | 2.39 X | ||||
| EBITDA | (252) | ||||
| Net Income | (254 K) | ||||
| Cash And Equivalents | 307 K | ||||
| Total Debt | 85 K | ||||
| Debt To Equity | 11.20 % | ||||
| Current Ratio | 1.07 X | ||||
| Book Value Per Share | 0.01 X | ||||
| Cash Flow From Operations | (561 K) | ||||
| Market Capitalization | 1.37 M | ||||
| Total Asset | 976 K | ||||
| Retained Earnings | (19.36 M) | ||||
| Working Capital | 891 K | ||||
About Vaxil Bio Performance
Evaluating Vaxil Bio's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Vaxil Bio has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Vaxil Bio has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 80.9 K | 71.9 K | |
| Return On Capital Employed | (0.29) | (0.30) |
Things to note about Vaxil Bio performance evaluation
Checking the ongoing alerts about Vaxil Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Vaxil Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Vaxil Bio generated a negative expected return over the last 90 days | |
| Vaxil Bio has some characteristics of a very speculative penny stock | |
| Vaxil Bio has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (254 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Vaxil Bio has accumulated about 307 K in cash with (561 K) of positive cash flow from operations. | |
| Latest headline from news.google.com: Vaxil Bio 14-Day RSI 41.18 - GuruFocus.com |
- Analyzing Vaxil Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Vaxil Bio's stock is overvalued or undervalued compared to its peers.
- Examining Vaxil Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Vaxil Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Vaxil Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Vaxil Bio's stock. These opinions can provide insight into Vaxil Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Vaxil Stock Analysis
When running Vaxil Bio's price analysis, check to measure Vaxil Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxil Bio is operating at the current time. Most of Vaxil Bio's value examination focuses on studying past and present price action to predict the probability of Vaxil Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxil Bio's price. Additionally, you may evaluate how the addition of Vaxil Bio to your portfolios can decrease your overall portfolio volatility.